In Brief: Hormel Buys CytoSport, FDA Warns On Drug Claims, Mira Health Consent Decree
This article was originally published in The Tan Sheet
Executive Summary
Hormel flexes Muscle Milk for protein; Hangover prevention claims are disease claims; Mira Health cannot resume supplement production without FDA permission; Batch production records require details; Laclede needs drug approval for vaginal products and U.S. & Korea ink organic equivalency agreement.
You may also be interested in...
Post Expects Stronger Nutrition Business Value To Emerge On Its Own, Plans IPO
Planned IPO of 25% of shares in nutrition business targets unlocking value currently held down by Post's other units. Its competitors in cereal space as well as firms across broader food industry also may determine their acquired nutritional businesses could be higher valued operating separately.
Biotene OTC Dry Mouth Competitor Remains On Market As GSK Litigates
Former Biotene owner Laclede ordered by US federal judge to stop using brand, now owned by GSK, to promote its competing line of Salivea dry mouth products. But judge rejected GSK’s request that the Salivea dry mouth product marketers are subject to a lifetime non-compete agreement.
Biotene OTC Dry Mouth Competitor Remains On Market As GSK Litigates
Former Biotene owner Laclede ordered by federal judge to stop using brand, now owned by GSK, to promote its competing line of Salivea dry mouth products. But judge rejected GSK’s request that the Salivea dry mouth product marketers are subject to a lifetime non-compete agreement.